Marc Rubin insider trades

Open-market stock purchases and sales by Marc Rubin, Director at Curis Inc, from SEC Form 4 filings since Jun 3, 2010.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +62%.

Recent trades

DateStockTradeValue
Jul 7, 2026CRIS Curis IncBought (not open market)$36K
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)$20K

Companies traded

  • CRIS Curis Inc: 2 buys, 1 sale, last Jul 7, 2026
  • GALT Galectin Therapeutics Inc: 3 buys, 2 sales, last Jan 23, 2025
  • TTNP Titan Pharmaceuticals Inc: 3 buys, last Jan 5, 2022
  • TTNP.OB Titan Pharmaceuticals Inc: 3 buys, last Dec 14, 2015
  • GALT.OB Galectin Therapeutics Inc: 1 buy, last Oct 18, 2011

Get free alerts when Marc Rubin files a new trade →